# Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead

Study · id `cardio:ct-nct03891329` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03891329](<https://clinicaltrials.gov/study/NCT03891329>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03891329

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT03891329. Allocation not applicable; no masking; primary purpose other. Start 2019-04-30 (actual); primary completion 2020-12-21 (actual). Results posted on 2024-09-27.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Started: 2019-04-30 (actual) (ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Primary completion: 2020-12-21 (actual) (ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Completion: 2021-09-24 (actual) (ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Results first posted: 2024-09-27 (ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Countries: Austria; Germany; Hungary; Latvia; Netherlands; Slovakia; Switzerland (ClinicalTrials.gov record NCT03891329, source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03891329-2024-09-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
- Condition: Heart Failure
- Condition: Tachyarrhythmia
- Intervention (Device): Acticor/Rivacor ICDs/CRT-Ds
- Intervention (Device): Plexa S DX
- Lead sponsor: Biotronik SE & Co. KG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: c243aa7ee60ba39d3fb79a1f4b26bfae141c94f1d4e8f5e9e97635a6745f2f03
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
